Healthcare – Page 6 – Go Job Zone

How would the inclusion of specialty drugs impact CPI-Rx? – Healthcare Economist

July 5, 2024

0 Comments

How would the inclusion of specialty drugs impact CPI-Rx? – Healthcare Economist

The Bureau of Labor Statistics’ (BLS’) Prescription Drug Consumer Price Index (CPI‐Rx) looks at price changes for drugs dispensed at outpatient retail pharmacies. However, ...

340B costs Medicaid $32b per year – Healthcare Economist

July 4, 2024

0 Comments

340B costs Medicaid $32b per year – Healthcare Economist

The 340B Drug Pricing Program is a federal initiative designed to help certain healthcare providers, known as “covered entities,” stretch their resources to better ...

HTA and cell and gene therapy – Healthcare Economist

July 2, 2024

0 Comments

HTA and cell and gene therapy – Healthcare Economist

A paper by Drummond et al. (2023) examines how health technology assessment bodies deal with the challenge of value ...

Drug shortages in the US – Healthcare Economist

June 27, 2024

0 Comments

Drug shortages in the US – Healthcare Economist

The good news: drug shortages in 2023 were down in the US from their recent peak between 2010 to ...

Empirical Estimates of Loss Aversion – Healthcare Economist

June 26, 2024

0 Comments

Empirical Estimates of Loss Aversion – Healthcare Economist

Kahneman and Tversky’s Prospect Theory posit that individuals have loss aversion. What is loss aversion? It means that individuals experience losses more intensely than ...

Is it time to start using a 2% discount rate? – Healthcare Economist

June 25, 2024

0 Comments

Is it time to start using a 2% discount rate? – Healthcare Economist

Cohen (2024) argues that health economists should start using 2% discount rates for health economic models. Why is that? ...

US Health Insurance Trends: 2024-2034 – Healthcare Economist

June 25, 2024

0 Comments

US Health Insurance Trends: 2024-2034 – Healthcare Economist

The Congressional Budget Office (CBO) recently relation projections of US health insurance levels between 2024 and 2034. In the ...

Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist

June 5, 2024

0 Comments

Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist

Why is it so hard to estimate the value of orphan drugs indicated for the treatment of rare diseases? ...

Time is money in drug development – Healthcare Economist

June 3, 2024

0 Comments

Time is money in drug development – Healthcare Economist

Delays in drug approvals cost pharmaceutical firms money. These costs include both lost sales as well as additional cost if clinical trials need to ...

Recent Medicare attempts to lower drug prices (beyond IRA) – Healthcare Economist

May 29, 2024

0 Comments

Recent Medicare attempts to lower drug prices (beyond IRA) – Healthcare Economist

Recently, the Inflation Reduction Act (IRA) is getting a lot of attention, particularly for its provision that allows CMS to start drug price negotiation ...

Tag: Healthcare

How would the inclusion of specialty drugs impact CPI-Rx? – Healthcare Economist

340B costs Medicaid $32b per year – Healthcare Economist

HTA and cell and gene therapy – Healthcare Economist

Drug shortages in the US – Healthcare Economist

Empirical Estimates of Loss Aversion – Healthcare Economist

Is it time to start using a 2% discount rate? – Healthcare Economist

US Health Insurance Trends: 2024-2034 – Healthcare Economist

Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist

Time is money in drug development – Healthcare Economist

Recent Medicare attempts to lower drug prices (beyond IRA) – Healthcare Economist

Call us

(469) 663-8558

For Candidates

Helpful Resources

About Us

Posts tagged "Healthcare"

Call us

(469) 663-8558

For Candidates

Helpful Resources

About Us

Ready to find your dream job?​

Ready to find your dream job?​

Ready to find your dream job?

Ready to find your dream job?